Lisanti Capital Growth, LLC

NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 5, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$372.9M2026 Q3
Positions95
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.22.4%

Lisanti Capital Growth, LLC reported 95 positions worth $372.9M as of September 30, 2026 (13F filed November 5, 2026). Largest holding: CORT (2.8%). Biggest move: exit BTSG ($10.8M).

10 / 95 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 CORTCorcept Therapeutics$10.3M2.76%89,350——-39.9%
▸ 2 HNGEHinge Health$9.9M2.65%101,660——+24.7%
▸ 3 KNSAKiniksa Pharmaceuticals$9.6M2.59%129,250——+26.3%
▸ 4 MGNIMagnite$9.1M2.45%360,985——+14.0%
▸ 5 CDNACareDx$8.5M2.27%130,200——+13.4%
▸ 6 HTFLHeartflow$7.7M2.07%155,295——-5.8%
▸ 7 ZETAZeta Global$7.7M2.07%244,525——+13.6%
▸ 8 GKOSGlaukos$7.2M1.94%44,100——+49.1%
▸ 9 FIVNFive9$6.8M1.83%201,110——-20.8%
▸ 10 ELFe.l.f. Beauty$6.5M1.73%63,990——+14.8%

Pro Feature

The remaining 85 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Lisanti Capital Growth, LLC hold as of Q3 2026?

Lisanti Capital Growth, LLC reported 95 positions worth $372.9M in its Q3 2026 13F filing. Largest positions: CORT (2.8%), HNGE (2.7%), KNSA (2.6%), MGNI (2.4%) and CDNA (2.3%).

What did Lisanti Capital Growth, LLC buy in Q3 2026?

New positions: CDNA, GKOS, ELF, BMRN and TWST (52 in all). Added to: PI, DGII, KNSA, ALNT and MGNI (13 in all).

What did Lisanti Capital Growth, LLC sell in Q3 2026?

Reduced: LIND, XMTR, HNGE, ZETA and SEI (29 in all). Sold out entirely: BTSG, ALGM, MIRM, CRS and DY (66 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.